Phase 2 Multi-Site Clinical Study: Abatacept Combined with a Calcineurin Inhibitor and Methotrexate for Graft versus Host Disease Prophylaxis: A Randomized Controlled Trial

Project: Research project

Project Details

StatusFinished
Effective start/end date2/1/15 → 12/31/17

Funding

  • Seattle Children's Research Institute (IM103-311)
  • Bristol-Myers Squibb Company (IM103-311)